Sankyo Pharma Inc., the U.S. subsidiary of Tokyo-based Sankyo Co. Ltd., has signed a sales and marketing data agreement with Dendrite International Inc. The agreement covers a four-year term and extends and expands a seven-year working relationship between the two firms.
Under the terms of the agreement, Dendrite will host Sankyo Pharma’s server, and manage the pharmaceutical company’s customer information and business intelligence platforms. Dendrite will house Sankyo’s information within its Nucleus Pharma product, which will allow users throughout Sankyo to access the information.
Network
